Sorry, this entry is only available in Italian. PharmaNutra al fianco di SIdEM (SocietĂ Italiana di Emaferesi e Manipolazione Cellulare) […]
2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. December’s market data*, […]
On 5ᵗʰ February, Midcap produced the “Small Touch” survey highlighting how PharmaNutra is performing more consistently that its peers. As […]
Sorry, this entry is only available in Italian. La terza edizione Italian Mid Cap Conference organizzata da Mediobanca si è […]
Le principali cause della stanchezza cronica e dei dolori muscolari diffusi.
The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […]
Sorry, this entry is only available in Italian. Questa mattina hanno avuto inizio sul mercato MTA – segmento STAR di […]
PharmaNutra and Zambon extend their collaboration to introduce two new Sucrosomial® Iron-based products to the Brazilian market. After the […]
The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]
The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]
PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]
Sorry, this entry is only available in Italian. PharmaNutra lancia una nuova campagna TV, radio e digital dedicata al complemento […]